With Donald Trump reaping his lowest approval rating of all-time, it’s only natural he’d scramble to throw voters a bone. Apparently, that came in the form of a huge government-mediated discount on the blockbuster weight loss drugs known as GLP-1s, like Wegovy and Zepbound. As reported by the Washington Post prior to the event, Trump announced the pharmaceutical giants Eli Lilly and Novo Nordisk will lower the price of their weight-loss drugs for some patients on Medicare and Medicaid. It’s a startlingly generous public health move from the president, whose own conservative policies have made health insurance, SSRIs, and weight loss drugs prohibitively more expensive for US citizens. More on Trump: President Trump Posts AI Video of Himself Spraying Explosive Diarrhea on Peaceful Protestors